Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04787718 · ClinicalTrials.gov registry record · NA

Almond for Physical Performance

A NA study, sponsored by San Diego State University.

Completed
Registry status
NA
Development phase
30
Enrollment target

NCT04787718: Completed NA study, sponsored by San Diego State University.

NCT04787718 is a NA study that has completed, run by San Diego State University. The registered enrollment target is 30 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04787718, a NA study, has completed, sponsored by San Diego State University.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target

Study Summary

Investigators specific aims are to compare the effects of consuming daily snacks of raw, shelled, unsalted almonds (2.0 ounces) versus an isocaloric amount of another commonly consumed snack food (pretzels) on energy (vigor) perception and physical activity, exercise performance (VO2max and measures of strength), strength and power performance as well as muscle soreness recovery after strenuous eccentrically-biased exercise.

Primary Outcome

Energy (vigor) perception will be assessed using POMS questionnaire

Interventions

  • OTHER Control group
  • OTHER Almond

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2020-07-15
Est. Completion 2022-05-03
Phase NA
San Diego State University

118 total trials

What the finished NCT04787718 record still lists

NCT04787718 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).

The record links to 0 conditions, and to 2 interventions - of which Control group is the first listed.

NCT04787718 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT04787718 about?

NCT04787718 is a clinical study titled "Almond for Physical Performance". Investigators specific aims are to compare the effects of consuming daily snacks of raw, shelled, unsalted almonds (2.0 ounces) versus an isocaloric amount of another commonly consumed snack food (pretzels) on energy (vigor) perception and physical activity, exercise performance (VO2max and measures...

What is the current status of trial NCT04787718?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2020-07-15. Estimated completion is 2022-05-03.

What interventions are being tested in trial NCT04787718?

The interventions under investigation include: Control group (OTHER), Almond (OTHER).

Who is sponsoring clinical trial NCT04787718?

This trial is sponsored by San Diego State University, which has 118 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT04787718's enrollment target sits among peer trials

30 1593rd of 2000 higher than 299 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04787718, the US trial registry maintained by the National Library of Medicine. NCT04787718 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.